Thu, 25 Apr 2019 12:22:31 GMT
AbbVie tops analysts' Q1 revenue forecasts
Drugmaker AbbVie reported on Thursday its Q1 revenue results of $4.45B topped Wall Street's estimates for a drop to $4.38B, as a sales decline of its rheumatoid arthritis drug treatment Humira was not as sharp as expected.